Fluorescent in situ Hybridization (FISH) is a cytogenetic diagnostic technique that utilizes DNA fragments labeled with a fluorescent tag to highlight the location, presence, or rearrangement of genetic loci. Thus, FISH probes enable clinicians and researchers to accurately determine a specific genetic abnormality, whose revelation can answer to key questions in disease diagnosis, prognosis, and enable the selection of the ideal treatment. FISH probes also aid in drug development and biomarker validation.

Being highly specialized in FISH technology (Fluorescence In-Situ Hybridization), the company has developed FISH probes for more than one million biomarkers, covering a wide range of mutations/diseases. Some of them are listed below:

  • Solid Tumors (melanoma Colorectal Cancer, Pancreatic Cancer, etc.)
  • Oncohematology (AML, ALL, Lymphoma, etc.)
  • Prenatal chromosomal abnormalities
  • Breast Cancer
  • Lung Cancer

ATROPOS is proud to be cooperating with Empire Genomics to bring FISH technology into Cytogenetics labs. Our team, working closely with labs and the expert team of our supplier can answer to any technical need you may have. Yet, if a probe is not listed in the company’s probe catalogue, a custom solution can be created for you.

You can go through our FISH probe catalogue that are available at the moment and contact us for further assistance.